DongBang Medical동방메디컬
240550 · KOSDAQ · ₩240550 · 동방메디컬
- Market cap
- ₩111B
- Enterprise value
- ₩116B
- P/E
- 6.9×
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- 12.0%
- Net margin
- 12.9%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−45.1% from the high
₩4,500Today: ₩5,270 – ₩5,490₩9,660
Returns
- 1W−6.0%
- 1M−15.6%
- 3M+11.6%
- 6M−26.0%
- YTD−32.1%
- 1Y−44.6%
- Volume today
- 56,711
- 0.6× the 20-day average
- Traded today
- ₩304M
- Listed shares
- 20,933,940
- EPS (12 months)
- ₩770
- Earnings yield 14.5%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 37 of 100 (50 is a normal day for this stock).
- MomentumWeak-12.5% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
DongBang Medical stock overview
DongBang Medical (동방메디컬, KRX: 240550) is listed on KOSDAQ, in the Medical & precision devices sector. The company, founded in 1985, manufactures and sells Korean medicine medical devices, such as disposable acupuncture needles and disposable cupping cups, and aesthetic medical devices, including hyaluronic acid dermal fillers, cannulas, needles and absorbable sutures. Its shares closed at ₩5,300 on Oct 28, 2026, down 1.12% on the day, giving it a market value of ₩111B.
Key facts
- Market cap
- ₩111B
- Sector
- Medical & precision devices
- Latest price change
- −1.12%
- As of
- Oct 28, 2026
- Main business
- The company, founded in 1985, manufactures and sells Korean medicine medical devices, such as disposable acupuncture needles and disposable cupping cups, and aesthetic medical devices, including hyaluronic acid dermal fillers, cannulas, needles and absorbable sutures.
Quick answers about DongBang Medical
- What does DongBang Medical do?
- The company, founded in 1985, manufactures and sells Korean medicine medical devices, such as disposable acupuncture needles and disposable cupping cups, and aesthetic medical devices, including hyaluronic acid dermal fillers, cannulas, needles and absorbable sutures. It sells these under its own brands in South Korea and exports to around 50 countries across Asia, North America, South America and Europe, with customers including hospitals, pharmaceutical companies and distributors.
- What is the market cap of DongBang Medical?
- The market capitalisation of DongBang Medical was ₩111B at the close on Oct 28, 2026.
- Who are the largest shareholders of DongBang Medical?
- According to the latest official filings, the largest reported holders are Kim Geun-sik (49.62%, as of Mar 6, 2025); Wonik New Growth 2020 Private Equity Fund (4.21%, as of Apr 7, 2025); Choi Nak-i (0.24%, as of Feb 23, 2026).
- When is the next earnings report from DongBang Medical?
- Korean companies rarely announce results dates in advance. Based on when DongBang Medical filed the same report in past years, its next 3q results is expected around Nov 25, 2026.
Company profile
The company, founded in 1985, manufactures and sells Korean medicine medical devices, such as disposable acupuncture needles and disposable cupping cups, and aesthetic medical devices, including hyaluronic acid dermal fillers, cannulas, needles and absorbable sutures. It sells these under its own brands in South Korea and exports to around 50 countries across Asia, North America, South America and Europe, with customers including hospitals, pharmaceutical companies and distributors.
Written by AI from the company's latest annual report.
- Korean name
- 동방메디컬
- Themes
- Medical devices
- CEO
- 김근식
- Founded
- Dec 2014
- Listed
- Feb 2025
- Listed shares
- 20,933,940
- Fiscal year ends
- Month 12
- Website
- www.dongbangmedical.co.kr/
Similar companies
- TSE131290 · ₩3T₩275,000+5.77%
- Kctech281820 · ₩1.9T₩95,500+3.92%
- Classys214150 · ₩1.8T₩27,000+1.89%
- Park Systems140860 · ₩1.6T₩229,500+1.77%
- DI003160 · ₩1.2T₩43,300+14.55%
- LivsMed491000 · ₩1.1T₩43,650+17.65%
- Curiox Biosystems445680 · ₩1.1T₩62,400+0.16%
- Seers458870 · ₩943B₩24,600−6.46%
Recent filings
See all- Investor relations (IR) eventSep 8, 2026
- Investor relations (IR) eventSep 8, 2026
- Results of Extraordinary Shareholders' MeetingAug 28, 2026
- Change of CEOAug 28, 2026
- Amended: Quarterly report (Mar 2026)Aug 14, 2026
Titles in Korean until English translations are added.
Also known as: DongBang Medical / 동방메디컬 / 240550 / KRX:240550
Source: KRX statistical information